Codexis to Present at the UBS Virtual Healthcare Conference
REDWOOD CITY, Calif., May 11, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]
Carriage Services Announces First Quarter Earnings Release and Conference Call Schedule
HOUSTON, May 11, 2020 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2020 first quarter […]
TerraForm Power Reports First Quarter 2020 Results
NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — TerraForm Power, Inc. (Nasdaq: TERP) (“TerraForm Power”) today reported financial results for […]
Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights
DEVON, Pa., May 11, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States
SAN JOSE, Calif., May 11, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
GNC Holdings, Inc. Reports First Quarter 2020 Results
Net loss of $200.1 million for the first quarter of 2020, compared with net loss of $15.3 million for the […]
U.S. Well Services Announces First Quarter 2020 Financial and Operational Results
HOUSTON, May 11, 2020 (GLOBE NEWSWIRE) — U.S. Well Services, Inc. (the “Company”, “U.S. Well Services” or “we”) (NASDAQ: USWS) […]
TSX News -
Gran Colombia Gold Proposes to Merge With Guyana Goldfields and Gold X to Create a High-Growth, Latin American-Focused Intermediate Gold Producer
TORONTO, Ontario and VANCOUVER, British Columbia, May 11, 2020 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (“Gran Colombia”) (TSX: GCM; […]
Canada’s Next Gold Mine on Track for First Gold Pour in Q4
VANCOUVER, British Columbia, May 11, 2020 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (TSX-V: PGM, LSE: PUR) (“PureGold” or the […]
Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million
— Announced Initiation of Funding from BARDA for All FDA Required Post-Marketing Studies and Security […]
